• Japanese
  • Korean
  • Chinese
Cover Image

Bioabsorbable Stents

This report analyzes the worldwide markets for Bioabsorbable Stents in Thousand Units. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2018. The report profiles 16 companies including many key and niche players such as Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, BIOTRONIK SE & Co. KG, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., and REVA Medical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Prelude
  • Evolution of Coronory Stents
  • Current Global Coronory Stent Scenario - A Few Key Facts
  • Bioabsorbable Stents Poised to Replace Drug-Eluting Stents in Future
  • Market Overview
  • Current & Future Analysis
  • Growth Drivers
  • Restenosis - the Real Growth Driver
  • Aging Population Propels Coronary Stents Market
  • Limitations and Challenges Ahead
  • Technological Challenges
  • Safety- Efficacy Factor
  • Regulatory Challenges
  • Price Factor
  • Threats to Coronary Stents - Alternative Therapies/Devices
  • Cell Transplantation - A Threat to Coronary Stents
  • Regulations for Conducting Clinical Trials Bioabsorbable Stents in Select Regions
  • The United States
  • Europe
  • Australia
  • Competitive Scenario
  • Focus on Select Bioabsorbable Stents
  • Absorb® (Abbott Laboratories, US)
  • ART Bioabsorbable Stent (Arterial Remodeling Technologies, France)
  • DREAMS (BIOTRONIK, Germany)
  • DESolve™ Coronary Scaffold (Elixir Medical, US)
  • IGAKI-TAMAI® (Kyoto Medical Planning, Japan)
  • ReZolve® (REVA Medical Inc., US)

2. PRODUCT OVERVIEW

  • Coronary Artery Disease-A Perspective
  • Treatment Options for Coronary Artery Disease
  • Percutaneous Coronary Intervention (PCI)
    • Coronary Stenting
  • Types of Coronary Stents
  • Bare Metal Stents (BMS)
  • Drug Eluting Stents (DES)
  • Bioabsorbable Stents
    • Design and Composition of Bioabsorbable stents
    • Different Types of Bioabsorbable Stents
      • Metallic Bioabsorbable Stents
      • Polymer Bioabsorbable Stents
    • Degradation Period of Select Bioabsorbable Materials
    • Advantages of Bioabsorbable stents
    • Challenges
  • Other Treatment Options for Coronary Heart Disease
  • Coronary Artery Bypass Grafting (CABG)
  • Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)
  • TransMyocardial Laser Revascularization (TMR)
  • Peripheral Arterial Disease: Understanding the Stealthy Peril
  • Treatment for PAD
  • Lifestyle Changes
  • Medication
  • Surgery
  • Stenting- A Treatment Option for PAD
  • Definition of Key Endpoints Used for Assessing Efficiency of Stents
  • MACE (Major Adverse Cardiac Events)
  • Restenosis
  • Stent Thrombosis
  • Target Lesion Revascularization (TLR)

3. PRODUCT LAUNCH/INTRODUCTION

  • Abbott Laboratories Launches Absorb™ BVS in Europe and Other Select Geographies

4. RECENT INDUSTRY ACTIVITY

  • Abbott Laboratories Initiates ABSORB III Clinical Trial in the US
  • ART Conducts First-in-Human Implant of ART Bioabsorbable Stent
  • Kyoto Medical Planning Releases Data to Demonstrate Efficacy of IGAKI-TAMAI® Stent
  • REVA Medical Receives Clearance to Conduct Clinical Trials for ReZolve® in Brazil and Germany
  • Xenogenics Acquires Ideal™ BioStent Assets from Investment Funds
  • ART Discloses Data for ART Bioabsorbable Stent Platform

5. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories (US)
  • Amaranth Medical, Inc. (US)
  • Arterial Remodeling Technologies SA (France)
  • BIOTRONIK SE & Co. KG (Germany)
  • Elixir Medical Corporation (US)
  • Kyoto Medical Planning Co., Ltd. (Japan)
  • REVA Medical, Inc. (US)

6. GLOBAL MARKET PERSPECTIVE

    • Table 1: World Current and Future Analysis for Bioabsorbable Stents by Geographic Region - US, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales in '000 Units for Years 2013 through 2018 (includes corresponding Graph/Chart)
    • Table 2: World 6-Year Perspective for Bioabsorbable Stents by Geographic Region - Percentage Breakdown of Volume Sales for US, Europe, Asia-Pacific, and Rest of World Markets for Years 2013 and 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Market Overview
    • Growth
    • Coronary Artery Disease - A US Perspective
    • Baby Boomers Boost Coronary Stent Market
    • Challenges Ahead
    • Current and Future Analysis
    • Products in the Pipeline
    • Competitive Scenario
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 3: The US Current and Future Analysis for Bioabsorbable Stents with Annual Sales in '000 Units for Years 2013 through 2018 (includes corresponding Graph/Chart)

2. EUROPE

  • A. Market Analysis
    • Overview
    • Growth Drivers
    • Cardiovascular Disease in Europe - A Perspective
    • Highly Diverse Europe
    • Product Launch
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 4: European Current and Future Analysis for Bioabsorbable Stents with Annual Sales in '000 Units for Years 2013 through 2018 (includes corresponding Graph/Chart)

3. ASIA-PACIFIC

  • A. Market Analysis
    • Overview
    • A Few Key Facts
    • Asia-Pacific - A Price Sensitive Market
    • Growth drivers
    • Current and Future Analysis
    • A Regional Perspective
      • Japan
      • Prospects Weighed down by Regulatory Entanglements
      • Japanese Coronary Stents Command Higher Prices
      • Competitive Landscape
      • China
      • Healthcare Reforms to Propel Stent Market
    • Strategic Corporate Development
    • Kyoto Medical Planning Co., Ltd. - A Key Player
  • B. Market Analytics
    • Table 5: Asia-Pacific Current and Future Analysis for Bioabsorbable Stents with Annual Sales in '000 Units for Years 2013 through 2018 (includes corresponding Graph/Chart)

4. REST OF WORLD

  • Market Analysis
    • Table 6: Rest of World Current and Future Analysis for Bioabsorbable Stents with Annual Sales in '000 Units for Years 2013 through 2018 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Show More
Pricing
Get Notified
Email me when related reports are published